SCHEMBL9587777

SCHEMBL9587777

CCCC(C([O])=O)c1ccc(OC)c(OC)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.47
PPARG P37231 1/20 0.46
PPARD Q03181 1/20 0.46
PPARA Q07869 1/20 0.46
LMNA P02545 2/20 0.45
SLC6A4 P31645 1/20 0.45
HIF1A Q16665 1/20 0.44
HPGD P15428 1/20 0.44
KCNQ2 O43526 1/20 0.44
PDE4A P27815 2/20 0.43
PDE4B Q07343 2/20 0.43
PDE4C Q08493 2/20 0.43
PDE4D Q08499 2/20 0.43
ALDH1A1 P00352 2/20 0.43
LDHA P00338 1/20 0.43
CYP2C19 P33261 1/20 0.43
KDM4E B2RXH2 1/20 0.42
MAPT P10636 1/20 0.42
HTT P42858 1/20 0.42
AKR1C3 P42330 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9588933 0.91 SMN1; SMN2 (0.45) ACHEPPARGPPARDPPARALMNA
SCHEMBL9589600 0.89 PPARG (0.50) ACHEPPARGPPARDPPARALMNA
SCHEMBL29378424 0.88 ACHE (0.50) ACHEPPARGPPARDPPARALMNA
SCHEMBL9587784 0.88 ACHE (0.54) ACHEPPARGPPARDPPARALMNA
SCHEMBL5194239 0.84 SLC6A4 (0.57) LMNASLC6A4HIF1AHPGDALDH1A1
SCHEMBL7179479 0.82 PPARG (0.49) ACHEPPARGPPARDPPARALMNA
SCHEMBL27586700 0.81 ACHE (0.49) ACHEPPARGPPARDPPARALMNA
SCHEMBL5158784 0.79 ACHE (0.51) ACHEPPARGPPARDPPARALMNA
SCHEMBL6432599 0.79 PAX8 (0.53) ACHEPPARGPPARDPPARALMNA
SCHEMBL30990182 0.79 ACHE (0.54) ACHEPPARGPPARDPPARALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5190946-A Piperazine compounds restore sensitivity to drug resistant cancer cells HOFFMANN-LA ROCHE INC. (US) 1993-03-02 US claimed
US-5190946-A Piperazine compounds restore sensitivity to drug resistant cancer cells HOFFMANN-LA ROCHE INC. (US) 1993-03-02 US disclosed
EP-0443569-A2 Diamine derivatives and their use in oncology F. HOFFMANN-LA ROCHE AG (CH) 1991-08-28 EP disclosed